Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 25, 2025 09:15 ET | Source: SNS Insider pvt ltd

Spinal Muscular Atrophy Treatment Market to Hit USD 16.28 Billion by 2032, Driven by Early Diagnosis and Advanced Therapies - SNS Insider

Austin, July 25, 2025 (GLOBE NEWSWIRE) -- Spinal Muscular Atrophy Treatment Market Size & Trends: According to SNS Insider, The Spinal Muscular Atrophy Treatment Market was estimated at USD...
June 06, 2024 10:48 ET | Source: Research and Markets

Spinal Muscular Atrophy Market and Epidemiology Forecast, 2024-2034

Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Spinal Muscular Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
February 15, 2024 17:02 ET | Source: PMI

Spinal Muscular Atrophy Market: Navigating Therapeutic Advances towards USD 5.6 Billion by 2034, with a CAGR of 14.80% - By PMI

Covina, Feb. 15, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Spinal Muscular Atrophy Market size was valued at about USD 1.4 Billion in 2024 and expected to grow at CAGR of...
October 31, 2023 13:00 ET | Source: DelveInsight Business Research LLP

Spinal Muscular Atrophy Market to Grow Rapidly During the Forecast Period (2019–2032), Assesses DelveInsight | Key Players - Biogen, NMD Pharma, Novartis, Roche, Biohaven Pharmaceuticals, Scholar Rock, AnnJi Pharmaceutical

New York, USA, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Spinal Muscular Atrophy Market to Grow Rapidly During the Forecast Period (2019–2032), Assesses DelveInsight | Key Players - Biogen, NMD Pharma,...
April 07, 2021 07:28 ET | Source: Research and Markets

Insights on the Spinal Muscular Atrophy Global Market to 2027 - Featuring AveXis, Biogen and Cytokinetics Among Others

Dublin, April 07, 2021 (GLOBE NEWSWIRE) -- The "Spinal Muscular Atrophy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19...
October 20, 2015 15:37 ET | Source: Transparency Market Research

Spinal Muscular Atrophy Phase 3 Candidate ISIS-SMNRx Expected to Reach USD 0.47 Billion in Sales in the U.S

Albany - NY, Oct. 20, 2015 (GLOBE NEWSWIRE) -- According to a new market report published by Transparency Market Research Spinal Muscular Atrophy Market: Pipeline Assessment, Size, Growth,...